Trial Profile
Third phase III study of Siquimod in healthy volunteers in the US and Canada
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Resiquimod (Primary)
- Indications Herpes genitalis; Herpes simplex virus infections
- Focus Therapeutic Use
- 28 Nov 2015 New trial record